Processa Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Processa Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Processa Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.42M, a 58% decline year-over-year.
  • Processa Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$11.8M, a 46.6% increase year-over-year.
  • Processa Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$11.5M, a 58.4% increase from 2022.
  • Processa Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$27.5M, a 127% decline from 2021.
  • Processa Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$12.1M, a 19.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$11.5M +$16.1M +58.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$27.5M -$15.4M -127% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$12.1M +$3M +19.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$15.1M -$11.2M -285% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$3.94M +$589K +13% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$4.52M -$2.72M -151% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-06
2017 -$1.8M +$119K +6.2% Jan 1, 2017 Dec 31, 2017 10-K/A 2019-04-08
2016 -$1.92M Jan 1, 2016 Dec 31, 2016 10-K 2018-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.